Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A noticeable shift is forming in the housing market as early 2026 data show momentum building. Prices are stabilizing...
A notable stake in Patterson-UTI Energy raises questions about a possible oil-service rebound. This article dives int...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
As AI stocks push valuations higher, a simple growth-based framework suggests paying earnings still cheap can still w...
Homebuyers saving for a two-year down payment should prioritize insured, liquid options over risky assets. Here’s a p...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
U.S. stocks drifted midweek as analysts rolled out fresh price targets on key names. Here’s a look at Wednesday’s top...
When planet fitness stock plunged after the latest earnings, investors suddenly faced a tough question: buy the dip o...
When a fund sells a big stake in Champion Homes, it can reveal more about market sentiment than a quarterly report. T...
Rare earths power the tech and defense backbone of modern economies. This guide explains how to identify your favorit...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...